The only differences are total amount, price per mg, supply duration and who they suit best
Under the Therapeutic Goods Act 1989, a person can commit an offence or be liable for a civil penalty if they advertise or cause the advertising of therapeutic goods that do not comply with the requirements in the Act or the Therapeutic Goods Advertising Code. The Business Briefing newsletter delivers major stories, exclusive coverage and expert opinion
Results may vary, but most people notice a reduction in cravings and appetite within the first few weeks, and visible weight loss usually begins after one or two months of consistent use
AA: Data curation, Visualization, Writing original draft
A study in The New England Journal of Medicine showed that tirzepatide (a dual GLP1/GIP receptor agonist) significantly reduced symptoms of OSA and weight in people with moderate to severe OSA and obesity